Tuesday, August 30, 2016

FDA approves Novartis biosimilar to Amgen's Enbrel

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novartis AG's biosimilar version of Amgen Inc's arthritis drug Enbrel.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)